NCRI 2019 | HER-2 conversion: a phenomenon in trastuzumab resistance

Russell Petty

Russell Petty, BMSC, MB ChB, PhD, MRCP, University of Dundee, Dundee, UK, talks about precision cancer biology and the phenomenon of HER-2 conversion that occurs in trastuzumab resistance. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit

Share this video